Cargando…

Clinicopathological significance of heterogeneic ezrin expression in poorly differentiated clusters of colorectal cancers

Multicellular structures, such as tumor buddings and poorly differentiated clusters (PDC), exist at the invasive front of colorectal cancers (CRC). Although it has been reported that CRC with PDC showed frequent lymph node metastases with a worse prognosis, the molecular markers of PDC that are resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Aikawa, Akane, Fujita, Hideto, Kosaka, Takeo, Minato, Hiroshi, Kiyokawa, Etsuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676292/
https://www.ncbi.nlm.nih.gov/pubmed/31175699
http://dx.doi.org/10.1111/cas.14093
_version_ 1783440743598129152
author Aikawa, Akane
Fujita, Hideto
Kosaka, Takeo
Minato, Hiroshi
Kiyokawa, Etsuko
author_facet Aikawa, Akane
Fujita, Hideto
Kosaka, Takeo
Minato, Hiroshi
Kiyokawa, Etsuko
author_sort Aikawa, Akane
collection PubMed
description Multicellular structures, such as tumor buddings and poorly differentiated clusters (PDC), exist at the invasive front of colorectal cancers (CRC). Although it has been reported that CRC with PDC showed frequent lymph node metastases with a worse prognosis, the molecular markers of PDC that are responsible for prognosis have not been identified. We here noticed for the first time that Ezrin, a regulator of the actin cytoskeleton, is expressed in the corner cells of PDC. We then aimed to verify whether heterogeneous Ezrin expression in PDC predicts the prognosis of CRC patients. We immunohistochemically analyzed Ezrin expression in PDC of 184 patients with completely resected stages I‐III CRC. We established the Ezrin corner score (ECS), which quantifies the tendency of Ezrin‐positive cells to accumulate at the corners of PDC. On the basis of ECS values, 2 indices, the mean ECS and the number of PDC with high ECS, were obtained. Both indices were significantly higher in CRC with lymphatic invasion, higher PDC grade, and presence of micropapillary (MP) PDC. The mean ECS‐high group showed shorter recurrence‐free survival than the mean ECS‐low group but without significance. The other index, the number of ECS‐high PDC, was significantly associated with recurrence‐free survival. These results suggest that Ezrin is involved in PDC progression and lymphatic invasion, and that ECS may be a marker for aggressive PDC.
format Online
Article
Text
id pubmed-6676292
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66762922019-08-06 Clinicopathological significance of heterogeneic ezrin expression in poorly differentiated clusters of colorectal cancers Aikawa, Akane Fujita, Hideto Kosaka, Takeo Minato, Hiroshi Kiyokawa, Etsuko Cancer Sci Original Articles Multicellular structures, such as tumor buddings and poorly differentiated clusters (PDC), exist at the invasive front of colorectal cancers (CRC). Although it has been reported that CRC with PDC showed frequent lymph node metastases with a worse prognosis, the molecular markers of PDC that are responsible for prognosis have not been identified. We here noticed for the first time that Ezrin, a regulator of the actin cytoskeleton, is expressed in the corner cells of PDC. We then aimed to verify whether heterogeneous Ezrin expression in PDC predicts the prognosis of CRC patients. We immunohistochemically analyzed Ezrin expression in PDC of 184 patients with completely resected stages I‐III CRC. We established the Ezrin corner score (ECS), which quantifies the tendency of Ezrin‐positive cells to accumulate at the corners of PDC. On the basis of ECS values, 2 indices, the mean ECS and the number of PDC with high ECS, were obtained. Both indices were significantly higher in CRC with lymphatic invasion, higher PDC grade, and presence of micropapillary (MP) PDC. The mean ECS‐high group showed shorter recurrence‐free survival than the mean ECS‐low group but without significance. The other index, the number of ECS‐high PDC, was significantly associated with recurrence‐free survival. These results suggest that Ezrin is involved in PDC progression and lymphatic invasion, and that ECS may be a marker for aggressive PDC. John Wiley and Sons Inc. 2019-06-22 2019-08 /pmc/articles/PMC6676292/ /pubmed/31175699 http://dx.doi.org/10.1111/cas.14093 Text en © 2019 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Aikawa, Akane
Fujita, Hideto
Kosaka, Takeo
Minato, Hiroshi
Kiyokawa, Etsuko
Clinicopathological significance of heterogeneic ezrin expression in poorly differentiated clusters of colorectal cancers
title Clinicopathological significance of heterogeneic ezrin expression in poorly differentiated clusters of colorectal cancers
title_full Clinicopathological significance of heterogeneic ezrin expression in poorly differentiated clusters of colorectal cancers
title_fullStr Clinicopathological significance of heterogeneic ezrin expression in poorly differentiated clusters of colorectal cancers
title_full_unstemmed Clinicopathological significance of heterogeneic ezrin expression in poorly differentiated clusters of colorectal cancers
title_short Clinicopathological significance of heterogeneic ezrin expression in poorly differentiated clusters of colorectal cancers
title_sort clinicopathological significance of heterogeneic ezrin expression in poorly differentiated clusters of colorectal cancers
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676292/
https://www.ncbi.nlm.nih.gov/pubmed/31175699
http://dx.doi.org/10.1111/cas.14093
work_keys_str_mv AT aikawaakane clinicopathologicalsignificanceofheterogeneicezrinexpressioninpoorlydifferentiatedclustersofcolorectalcancers
AT fujitahideto clinicopathologicalsignificanceofheterogeneicezrinexpressioninpoorlydifferentiatedclustersofcolorectalcancers
AT kosakatakeo clinicopathologicalsignificanceofheterogeneicezrinexpressioninpoorlydifferentiatedclustersofcolorectalcancers
AT minatohiroshi clinicopathologicalsignificanceofheterogeneicezrinexpressioninpoorlydifferentiatedclustersofcolorectalcancers
AT kiyokawaetsuko clinicopathologicalsignificanceofheterogeneicezrinexpressioninpoorlydifferentiatedclustersofcolorectalcancers